第 1 到 44 筆結果,共 44 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2023 | Niraparib and Abiraterone Acetate for Metastatic Castration-Resistant Prostate Cancer | Chi, Kim N; Rathkopf, Dana; Smith, Matthew R; Efstathiou, Eleni; Attard, Gerhardt; Olmos, David; Lee, Ji Youl; Small, Eric J; Pereira de Santana Gomes, Andrea J; Roubaud, Guilhem; Saad, Marniza; Zurawski, Bogdan; Sakalo, Valerii; Mason, Gary E; Francis, Peter; Wang, George; Wu, Daphne; Diorio, Brooke; Lopez-Gitlitz, Angela; Sandhu, Shahneen; YU-CHIEH TSAI | Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 58 | 42 | |
2 | 2023 | The androgen receptor in bladder cancer | Chen, Jinbo; Huang, Chi-Ping; Quan, Chao; Zu, Xiongbing; Ou, Zhenyu; YU-CHIEH TSAI ; Messing, Edward; Yeh, Shuyuan; Chang, Chawnshang | Nature reviews. Urology | 4 | 0 | |
3 | 2023 | Selective inhibition of HDAC6 promotes bladder cancer radiosensitization and mitigates the radiation-induced CXCL1 signalling | YU-CHIEH TSAI ; Wang, Tzu-Yin; Hsu, Chia-Lang; WEI-CHOU LIN ; Chen, Jyun-Yu; Li, Jia-Hua; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG ; SHENG-FANG SU | British journal of cancer | 4 | 4 | |
4 | 2022 | Tumor-Derived C-C Motif Ligand 2 Induces the Recruitment and Polarization of Tumor-Associated Macrophages and Increases the Metastatic Potential of Bladder Cancer Cells in the Postirradiated Microenvironment | YUN CHIANG ; YU-CHIEH TSAI ; Wang, Chung-Chieh; FU-JEN HSUEH ; CHAO-YUAN HUANG ; Chung, Shiu-Dong; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | International journal of radiation oncology, biology, physics | 12 | 12 | |
5 | 2022 | The risk of subsequent malignancies in patients with renal cell carcinoma: A nationwide, population-based study | Lu, Yu Cheng; YU-CHIEH TSAI ; PO-MING CHOW ; Weng, Wen Ching; Huang, Wei Yi; SHIH-CHIEH CHUEH ; KAO-LANG LIU ; KUO-HOW HUANG | Urological Science | 0 | 0 | |
6 | 2021 | Preoperative ALBI grade predicts the outcomes in non-B non-C HCC patients undergoing primary curative resection | YU-CHIEH TSAI ; Sou F.-M.; Liu Y.-W.; Wu Y.-J.; Yong C.-C.; Chen D.-W.; Huang P.-Y.; Cho W.-R.; Chuang C.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Gastroenterology | 6 | 7 | |
7 | 2021 | Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma | Yang S.-Y.; Wang C.-C.; Chen K.-D.; Liu Y.-W.; Lin C.-C.; Chuang C.-H.; YU-CHIEH TSAI ; Yao C.-C.; Yen Y.-H.; Hsiao C.-C.; Hu T.-H.; Tsai M.-C. | BMC Cancer | 12 | 11 | |
8 | 2020 | Targeting human epidermal growth factor receptor 2 enhances radiosensitivity and reduces the metastatic potential of Lewis lung carcinoma cells | Tien Y.; CHIAO-LING TSAI ; Hou W.-H.; YUN CHIANG ; Feng-Ming Hsu ; YU-CHIEH TSAI ; CHIA-HSIEN CHENG | Radiation Oncology | 7 | 7 | |
9 | 2020 | Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial | Powles T.; van der Heijden M.S.; Castellano D.; Galsky M.D.; Loriot Y.; Petrylak D.P.; Ogawa O.; Park S.H.; Lee J.-L.; De Giorgi U.; B?gemann M.; Bamias A.; Eigl B.J.; Gurney H.; Mukherjee S.D.; Fradet Y.; Skoneczna I.; Tsiatas M.; Novikov A.; Su?rez C.; Fay A.P.; Duran I.; Necchi A.; Wildsmith S.; He P.; Angra N.; Gupta A.K.; Levin W.; Bellmunt J.; van der Heijden M.S.; Lee J.L.; Eigl B.J.; Mukherjee S.D.; Suarez C.; Westgeest H.; Flechon A.; Ou Y.-C.; Park I.; Matveev V.; P?rez-Valderrama B.; Cheng S.; Frank S.; Anido U.; Hamzaj A.; Retz M.; Sridhar S.; Scagliotti G.V.; Voortman J.; Alekseev B.; Alyasova A.; Komyakov B.; Dumez H.; Pavic M.; Kimura G.; Mizokami A.; Osanto S.; Arranz J.A.; Piersma D.; Shin S.J.; Karyakin O.; Delgado I.; Gonzalez J.L.; Pang S.-T.; Tran A.; Lipatov O.; Su W.-P.; Flaig T.; Alva A.; Park Kyong H.; Kopyltsov E.; Almagro E.; Domenech M.; Chang Y.-H.; Sautois B.; Ravaux A.; Aravantinos G.; Georgoulias V.; Mulder S.; Kim Y.J.; Kater F.; Chevreau C.; Tagawa S.; Zalewski P.; Joly F.; Hatiboglu G.; Gianni L.; Morelli F.; Tambaro R.; Hashimoto Y.; Nosov A.; Font A.; Rodriguez-Vida A.M.; Jones R.; Vasudev N.; Srinivas S.; Zhang J.; Gil T.; Finch D.; Grimm M.-O.; Su Y.-L.; Chowdhury S.; Hocking C.; Plas E.; North S.; Jensen N.V.; Theodore C.; Imkamp F.; Peer A.; Kobayashi T.; Sakai H.; Sassa N.; Yoshimura K.; Aarts M.; Ferreira Castro A.; Topuzov M.; Rodriguez J.F.; Vazquez F.J.; YU-CHIEH TSAI ; Crabb S.; Hussain S.; Bendell J.; Gross-Goupil M.; Gwenaelle G.; Berger R.; Statsenko G.; Evans L.; Drakaki A.; Somer B.; Davis I.; Lynam J.; Borges G.; Dettino A.; Fay A.P.; Martins G.; Zucca L.E.; Agerbaek M.; Kalofonos H.; Rosenbaum E.; Enokida H.; Kikukawa H.; Nishimura K.; Tamada S.; Uemura M.; Lopez Y.; Gietema J.; Slojewski M.; Fernandes I.; Smolin A.; Mazhar D.; Kalebasty A.R.; Carthon B.; Loidl W.; Franke F.; Girotto G.; Alimohamed N.; Macfarlane R.; Pappot H.; Niegisch G.; Mavroudis D.; Sella A.; Porta C.; Ebara S.; Nakamura M.; Obara W.; Okuno N.; Shinohara N.; Sugimoto M.; Suzuki A.; Tokuda N.; Uemura H.; Yamaguchi A.; Ramirez F.; Rozanowski P.; Wiechno P.; Keam B.; Kislov N.; Plaksin D.; Cicin I.; Kumar S.; Galsky M.D.; Petrylak D.P.; Rosales J.; Vaishampayan U.; Culine S.; Papandreou C.; Nara T.; Erman M.; Kreiger L.; Janoski J.; Rosa D.; Siqueira M.; Canil C.; Sengelov L.; Tourani J.-M.; Arai G.; Hashine K.; Kawakita M.; Nakaigawa N.; Nomi H.; Shiina H.; Suzuki H.; Yonese J.; Kuri R.; Macedo E.; Rivera S.; Villalobos Prieto A.; Polakiewicz-Gilowska A.; Zaucha R.; Lopes F.; Ponomarev R.; Pomerantz M.; Shariat S.; Luk C.; Lesniewski-Kmak K. | The Lancet Oncology | 302 | 274 | |
10 | 2020 | Current and future aspect of immunotherapy for advanced renal cell carcinoma | FU-JEN HSUEH ; YU-CHIEH TSAI | Urological Science | 3 | 3 | |
11 | 2020 | Androgen receptor-regulated circFNTA activates KRAS signaling to promote bladder cancer invasion | Chen J.; Sun Y.; Ou Z.; Yeh S.; Huang C.-P.; You B.; YU-CHIEH TSAI ; Sheu T.-J.; Zu X.; Chang C. | EMBO Reports | 57 | 53 | |
12 | 2020 | Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery | Cho W.-R.; Hung C.-H.; Chen C.-H.; Lin C.-C.; Wang C.-C.; Liu Y.-W.; Wu Y.-J.; Yong C.-C.; Chen K.-D.; YU-CHIEH TSAI ; Hu T.-H.; Tsai M.-C. | Scientific Reports | 17 | 14 | |
13 | 2019 | Nuclear Factor-κB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer | CHIANG, YUN ; Wang, Chung-Chieh; YU-CHIEH TSAI ; CHAO-YUAN HUANG ; YEONG-SHIAU PU ; CHIA-CHI LIN ; CHIA-HSIEN CHENG | Journal of clinical medicine | 8 | 7 | |
14 | 2019 | Programmed death-1 and programmed death ligand-1 blockade for advanced urothelial carcinoma | JHE-CYUAN GUO ; YU-CHIEH TSAI ; YEONG-SHIAU PU | Urological Science | 1 | 1 | |
15 | 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; CHIA-TUNG SHUN ; Shi C.-S.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 1 | 1 | |
16 | 2019 | Biological significance of GATA3, cytokeratin 20, cytokeratin 5/6 and p53 expression in muscle-invasive bladder cancer | Wang C.-C.; YU-CHIEH TSAI ; YUNG-MING JENG | PLoS ONE | 31 | 29 | |
17 | 2018 | Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; CHIA-TUNG SHUN ; Shi C.-S.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 8 | 9 | |
18 | 2017 | CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression | Chen P.-C.; Tai H.-C.; Lin T.-H.; Wang S.-W.; Lin C.-Y.; Chao C.-C.; HONG-JENG YU ; YU-CHIEH TSAI ; Lai Y.-W.; Lin C.-W.; Tang C.-H. | Oncotarget | 18 | 15 | |
19 | 2017 | Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population | Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI ; Huang S.-P.; Wu W.-J.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; Chung S.-D.; CHAO-YUAN HUANG | Urologic Oncology: Seminars and Original Investigations | 11 | 10 | |
20 | 2017 | A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement | YUN CHIANG ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Chia-Chi Lin ; CHIH-HUNG HSU ; ANN-LII CHENG ; YEONG-SHIAU PU | Journal of the Formosan Medical Association | 7 | 6 | |
21 | 2017 | Effects of short forest bathing program on autonomic nervous system activity and mood states in middle-aged and elderly individuals | Yu, Chia-Pin; Lin, Chia-Min; Tsai, Ming-Jer; YU-CHIEH TSAI ; Chen, Chun-Yu; MING-JER TSAI | International Journal of Environmental Research and Public Health | 120 | 95 | |
22 | 2016 | Differences in toxicity and outcome associated with circadian variations between patients undergoing daytime and evening radiotherapy for prostate adenocarcinoma | Feng-Ming Hsu ; Hou W.-H.; CHAO-YUAN HUANG ; CHIA-CHUN WANG ; CHIAO-LING TSAI ; YU-CHIEH TSAI ; HONG-JENG YU ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | Chronobiology International | 32 | 30 | |
23 | 2015 | Synergistic blockade of EGFR and HER2 by new-generation EGFR tyrosine kinase inhibitor enhances radiation effect in bladder cancer cells | YU-CHIEH TSAI ; Ho P.-Y.; KAI-YUAN TZEN ; Tuan T.-F.; Liu W.-L.; ANN-LII CHENG ; YEONG-SHIAU PU ; CHIA-HSIEN CHENG | Molecular Cancer Therapeutics | 25 | 26 | |
24 | 2015 | MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies | Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; WEI-CHOU LIN ; YU-CHIEH TSAI ; HONG-CHIANG CHANG ; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; YEONG-SHIAU PU ; KUO-HOW HUANG | Cancer Letters | 48 | 51 | |
25 | 2015 | MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma | Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; HONG-CHIANG CHANG ; Hsieh J.-T.; Wu J.-T.; CHIH-KANG CHIANG ; WEI-CHOU LIN ; YU-CHIEH TSAI ; Chou C.-T.; Hsu C.-H.; YEONG-SHIAU PU ; Shi C.-S.; KUO-HOW HUANG | Scientific Reports | 35 | 35 | |
26 | 2015 | Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma | Hu C.-Y.; YU-CHIEH TSAI ; SHUO-MENG WANG ; CHAO-YUAN HUANG ; Tai H.-C.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; WEI-CHOU LIN ; KUO-HOW HUANG | BioMed Research International | 7 | 3 | |
27 | 2014 | Estrogen receptor alpha prevents bladder cancer development via INPP4B inhibited Akt pathway in vitro and in vivo | Hsu I.; Yeh C.-R.; Slavin S.; Miyamoto H.; Netto G.J.; YU-CHIEH TSAI ; Muyan M.; Wu X.-R.; Messing E.M.; Guancial E.A.; Yeh S. | Oncotarget | 59 | 51 | |
28 | 2014 | Osteoblast-derived WISP-1 increases VCAM-1 expression and enhances prostate cancer metastasis by down-regulating miR-126 | HUAI-CHING TAI ; Chang A.-C.; HONG-JENG YU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Lai Y.-W.; Sun H.-L.; Tang C.-H.; Wang S.-W. | Oncotarget | 51 | ||
29 | 2013 | Targeting epidermal growth factor receptor/human epidermal growth factor receptor 2 signalling pathway by a dual receptor tyrosine kinase inhibitor afatinib for radiosensitisation in murine bladder carcinoma | YU-CHIEH TSAI ; Yeh C.-H.; KAI-YUAN TZEN ; Ho P.-Y.; Tuan T.-F.; YEONG-SHIAU PU ; ANN-LII CHENG ; CHIA-HSIEN CHENG | European Journal of Cancer | 26 | 24 | |
30 | 2012 | Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells | KUO-HOW HUANG ; Kuo K.-L.; Chen S.-C.; TE-I WENG ; Chuang Y.-T.; YU-CHIEH TSAI ; YEONG-SHIAU PU ; CHIH-KANG CHIANG ; Liu S.-H. | PLoS ONE | 34 | 27 | |
31 | 2012 | The selective inhibitory effect of a synthetic tanshinone derivative on prostate cancer cells | Xu D.; Lin T.-H.; Zhang C.; YU-CHIEH TSAI ; Li S.; Zhang J.; Yin M.; Yeh S.; Chang C. | Prostate | 19 | 18 | |
32 | 2012 | Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications. | YEONG-SHIAU PU ; CHAO-YUAN HUANG ; Chen J.Y.; Kang W.Y.; Lin Y.C.; Shiu Y.S.; Chuang S.J.; HONG-JENG YU ; Lai M.K.; YU-CHIEH TSAI ; Wu W.J.; Hour T.C. | Journal of biomedical science | 16 | 14 | |
33 | 2012 | Altered prostate epithelial development in mice lacking the androgen receptor in stromal fibroblasts | Yu S.; Yeh C.-R.; Niu Y.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Moses H.L.; Shyr C.-R.; Chang C.; Yeh S. | Prostate | 59 | 55 | |
34 | 2011 | Retrospective analysis of outcome differences in preoperative concurrent chemoradiation with or without elective nodal irradiation for esophageal squamous cell carcinoma | Feng-Ming Hsu ; JANG-MING LEE ; PEI-MING HUANG ; CHIA-CHI LIN ; CHIH-HUNG HSU ; YU-CHIEH TSAI ; Lee Y.-C.; CHIA-HSIEN CHENG | International Journal of Radiation Oncology Biology Physics | 38 | 36 | |
35 | 2009 | Down regulation of ABCD1 in human renal cell carcinoma | Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU | International Journal of Biological Markers | 9 | 9 | |
36 | 2009 | Association of clinical and dosimetric factors with postoperative pulmonary complications in esophageal cancer patients receiving intensity-modulated radiation therapy and concurrent chemotherapy followed by thoracic esophagectomy | Feng-Ming Hsu ; Lee Y.-C.; JANG-MING LEE ; CHIH-HUNG HSU ; CHIA-CHI LIN ; YU-CHIEH TSAI ; Wu J.-K.; CHIA-HSIEN CHENG | Annals of Surgical Oncology | 33 | 32 | |
37 | 2009 | Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Feng-Ming Hsu ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | International Journal of Radiation Oncology Biology Physics | 27 | 22 | |
38 | 2008 | Improved local control by surgery and paclitaxel-based chemoradiation for esophageal squamous cell carcinoma: Results of a retrospective non-randomized study | FENG-MING HSU ; CHIA-CHI LIN ; JANG-MING LEE ; YIH-LEONG CHANG ; CHIH-HUNG HSU ; YU-CHIEH TSAI ; Lee Y.-C.; CHIA-HSIEN CHENG | Journal of Surgical Oncology | 32 | 29 | |
39 | 2007 | Multifractionated paclitaxel and cisplatin combined with 5-fluorouracil and leucovorin in patients with metastatic or recurrent esophageal squamous cell carcinoma | CHIA-CHI LIN ; KUN-HUEI YEH ; CHIH-HSIN YANG ; CHIUN HSU ; YU-CHIEH TSAI ; Hsu W.-L.; ANN-LII CHENG ; CHIH-HUNG HSU | Anti-Cancer Drugs | 10 | 8 | |
40 | 2007 | Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; Keng H.-Y.; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Anti-Cancer Drugs | 32 | 29 | |
41 | 2007 | Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Urology | 24 | 21 | |
42 | 2007 | Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer | CHUNG-HSIN CHEN ; CHIA-TUNG SHUN ; KUO-HOW HUANG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; HONG-JENG YU ; YEONG-SHIAU PU | BJU International | 101 | 87 | |
43 | 2005 | Response of refractory osteosarcoma to thalidomide and celecoxib | YU-CHIEH TSAI ; CHEN-TU WU ; RUEY-LONG HONG | Lancet Oncology | 15 | 14 | |
44 | 2002 | Osteonecrosis of the femoral head in a human immunodeficiency virus type 1-infected patient with lipodystrophy | YU-CHIEH TSAI ; CHEN-HUA LIU ; Liao C.-H.; Chen M.-Y.; CHIEN-CHING HUNG | Journal of the Formosan Medical Association | 4 | 5 |